Global Innovative Platforms (GIPL) Liabilities and Shareholders Equity (2021 - 2026)
Global Innovative Platforms (GIPL) reported Liabilities and Shareholders Equity of $539,261 for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 157.8% from $209,160 a year earlier but down 8.9% from the prior quarter.
Powered by 
Analysis
Global Innovative Platforms (GIPL) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Global Innovative Platforms posted Liabilities and Shareholders Equity of $199,275.
- Liabilities and Shareholders Equity has a four-year compound annual growth rate of 425.2% (FY2021 to FY2025).
- By fiscal year, Liabilities and Shareholders Equity came in at $15.00 in FY2024 (-96.4%), $415.00 in FY2023 (-99.1%), $47,757 in FY2022 and $262.00 in FY2021.
- Five-year quarterly Liabilities and Shareholders Equity spans a low of $15.00 in fiscal Q4 2024 and a high of $591,958 in fiscal Q2 2026.
- Year over year, Liabilities and Shareholders Equity has now increased in each of the last three quarters, with growth averaging 91.9% over the last four quarters.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was fiscal Q2 2026 (growth of 254.6%); the low point was fiscal Q4 2023 (a decline of 99.1%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $591,958 (Q2 2026), $224,951 (Q1 2026) and $199,275 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Global Innovative Platforms | 24.88 Mn | 24.27 Mn | - | 539,261.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 539,261.00 |
| Mar 31, 2026 | 591,958.00 |
| Dec 31, 2025 | 224,951.00 |
| Sep 30, 2025 | 199,275.00 |
| Jun 30, 2025 | 209,160.00 |
| Mar 31, 2025 | 166,932.00 |
| Dec 31, 2024 | 148,459.00 |
| Sep 30, 2024 | 15.00 |
| Jun 30, 2024 | 10,146.00 |
| Mar 31, 2024 | 596.00 |
| Dec 31, 2023 | 1,685.00 |
| Sep 30, 2023 | 415.00 |
| Jun 30, 2023 | 361.00 |
| Mar 31, 2023 | 2,961.00 |
| Dec 31, 2022 | 64,403.00 |
| Sep 30, 2022 | 47,757.00 |
| Jun 30, 2022 | 262.00 |
| Mar 31, 2022 | 262.00 |
| Dec 31, 2021 | 262.00 |
| Sep 30, 2021 | 262.00 |
API Access
Global Innovative Platforms Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=GIPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "GIPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=GIPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();